These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24870597)

  • 1. MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.
    Kaymaz BT; Cetintaş VB; Aktan C; Kosova B
    Tumour Biol; 2014 Sep; 35(9):8733-42. PubMed ID: 24870597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
    Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
    Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis.
    Kaymaz BT; Selvi N; Gündüz C; Aktan C; Dalmızrak A; Saydam G; Kosova B
    Ann Hematol; 2013 Jan; 92(2):151-62. PubMed ID: 23053176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
    Bi CL; Zhang YQ; Li B; Guo M; Fu YL
    J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor miR-520a inhibits cell growth by negatively regulating PI3K/AKT signaling pathway in acute myeloid leukemia.
    Xiao J; Wan F; Tian L; Li Y
    Adv Clin Exp Med; 2024 Jul; 33(7):729-738. PubMed ID: 37855060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 Mediated miR-30a-5p Inhibition Enhances Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells.
    Cheng CC; Yang BL; Chen WC; Ho AS; Sie ZL; Lin HC; Chang CC
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance.
    Wu YY; Lai HF; Huang TC; Chen YG; Ye RH; Chang PY; Lai SW; Chen YC; Lee CH; Liu WN; Dai MS; Chen JH; Ho CL; Chiu YL
    Cell Death Dis; 2021 Oct; 12(10):908. PubMed ID: 34611140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.
    Nie ZY; Liu XJ; Zhan Y; Liu MH; Zhang XY; Li ZY; Lu YQ; Luo JM; Yang L
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
    Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
    Cancer Lett; 2015 Jan; 356(2 Pt B):597-605. PubMed ID: 25305453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
    Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
    Farhadi E; Zaker F; Safa M; Rezvani MR
    Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells.
    Ma LD; Zhou M; Wen SH; Ni C; Jiang LJ; Fan J; Xia L
    Leuk Lymphoma; 2010 Jul; 51(7):1326-36. PubMed ID: 20497005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect and mechanism of miR-135a-5p/CXCL12/JAK-STAT axis on inflammatory response after myocardial infarction.
    Guo XY; Liu QL; Liu W; Cheng JX; Li ZJ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12912-12928. PubMed ID: 33378042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
    Shen N; Huang X; Li J
    Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
    Nie ZY; Yao M; Yang Z; Yang L; Liu XJ; Yu J; Ma Y; Zhang N; Zhang XY; Liu MH; Jiang LL; Luo JM
    J Exp Clin Cancer Res; 2020 Jan; 39(1):17. PubMed ID: 31952546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
    Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
    Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.
    Venturini L; Battmer K; Castoldi M; Schultheis B; Hochhaus A; Muckenthaler MU; Ganser A; Eder M; Scherr M
    Blood; 2007 May; 109(10):4399-405. PubMed ID: 17284533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.
    Bhutra S; Lenkala D; LaCroix B; Ye M; Huang RS
    PLoS One; 2014; 9(12):e115003. PubMed ID: 25506832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells.
    Liao XH; Xiang Y; Yu CX; Li JP; Li H; Nie Q; Hu P; Zhou J; Zhang TC
    Oncotarget; 2017 Feb; 8(9):15763-15774. PubMed ID: 28178652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.